HELP · Helus Pharma Inc. · Investor Relations
$10.52
+0.16 (+1.54%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$757.00M
Shares
73.07M
Volume · Oct 27
1.53M
Avg daily vol (3M)
1.71M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-10-21 | Helus Pharma Investor Presentation | Presentation |
| 2026-09-23 | TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit | Webcast |
| 2026-09-16 | Morgan Stanley 24th Annual Global Healthcare Conference | Conference |
| 2026-09-14 | H.C. Wainwright 28th Annual Global Investment Conference | Conference |
| 2026-09-11 | 2026 Cantor Global Healthcare Conference | Conference |
| 2026-08-12 | Canaccord Genuity 46th Annual Growth Conference | Conference |
| 2026-06-15 | H.C. Wainwright 7th Annual Neuro Perspectives Conference | Conference |
| 2026-06-04 | Jefferies Global Healthcare Conference | Conference |
| 2026-05-04 | Milken Institute Global Conference | Conference |
| 2025-11-17 | Jefferies Global Healthcare Conference in London | Conference |
| 2025-11-13 | Q2 Financial Results Conference Call and Webcast | Earnings call |
Source: https://ir.cybin.com/
Key facts
CIK
1833141
CUSIP
23256X407
13F (30d)
13 filings
13 filers
Visit website
Investor relations